Normal view MARC view ISBD view

Drug discovery for Alzheimer's disease: the end of the beginning. [electronic resource]

By:

Refolo, Lorenzo M

Contributor(s):

Fillit, Howard M

Producer: 20041230Description: 1-8 p. digitalISSN:

0895-8696

Subject(s):

Online resources:

Available from publisher's website

In: Journal of molecular neuroscience : MN vol. 24

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Editorial; Historical Article

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9
10
11

1 [The role of the sympathoadrenal and opioid systems in the pathogenesis of "silent" myocardial ischemia in ischemic heart disease].
by Ermakovich, I I
2 [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
by Dubenko, O E
3 [Asymptomatic myocardial ischemia in the dynamics of anaprilin and korinfar treatment].
by Volkov, V I
4 [A chromatographic method of determining verapamil and norverapamil in blood plasma].
by Kobzar', A I
5 [A rapid method of evaluating the morphofunctional status of thrombocytes].
by Ladnyĭ, A I
6 [Chymase in the system proteinase-proteinase inhibitor in pathogenesis of hypertension].
by Samokhina, L M
7 [A comparative evaluation of the antianginal action of commercially and noncommercially produced validol in neurocirculatory dystonia and stenocardia].
by Bondarenko, I P
8 [Thrombocytic hemostasis and the system of vasoactive prostanoids in IHD patients with hypoalphacholesterolemia].
by Chernyshov, V A
9 [Effect of physical loading on metabolic indices of lipids in patients with chronic ischemic heart disease].
by Volkov, V I
10 [The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
by Ermakovich, I I
11 [The effect of a controlled physical load on the level of cyclic adenosine monophosphate in plasma and thrombocytes].
by Volkov, V I

Close